An Open-Label, Cohort Dose Escalation Study to Assess the Safety and Efficacy of F-652 in Patients With Alcoholic Hepatitis
Phase of Trial: Phase I/II
Latest Information Update: 05 May 2016
At a glance
- Drugs F 652 (Primary)
- Indications Alcoholic hepatitis
- Focus Adverse reactions
- Acronyms TREAT 008
- 29 Apr 2016 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 29 Apr 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.
- 29 Apr 2016 Status changed from not yet recruiting to recruiting.